DIFFERENTIAL SENSITIVITY OF PANCREATIC ADENOCARCINOMA CELL-LINES TO CHEMOTHERAPEUTIC-AGENTS IN CULTURE
- 1 January 1983
- journal article
- research article
- Vol. 67 (4) , 355-361
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- CHEMOTHERAPY OF PANCREATIC ADENOCARCINOMA - INITIAL REPORT ON 2 TRANSPLANTABLE MODELS IN THE SYRIAN-HAMSTER1982
- TRIALS OF SINGLE-AGENT AND COMBINATION CHEMOTHERAPY FOR ADVANCED CANCER OF THE PANCREAS1981
- Human cell line (COLO 357) of metastatic pancreatic adenocarcinomaInternational Journal of Cancer, 1980
- TREATMENT OF MOUSE-TUMORS WITH 7-CON-O-METHYLNOGAROL AND OTHER ANALOGS OF THE ANTHRACYCLINE ANTIBIOTIC, NOGALAMYCIN1979
- ACTIVITY OF A NOVEL ANTHRACENEDIONE, 1,4-DIHYDROXY-5,8-BIS[[[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]]-9,10-ANTHRACENEDIONE DIHYDROCHLORIDE, AGAINST EXPERIMENTAL-TUMORS IN MICE1979
- TRANSPLANTABLE DUCTAL ADENOCARCINOMA OF THE SYRIAN-HAMSTER PANCREAS1979
- Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group reportCancer, 1978